These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 27722966

  • 21. Diabetes treatments and risk of amputation, blindness, severe kidney failure, hyperglycaemia, and hypoglycaemia: open cohort study in primary care.
    Hippisley-Cox J, Coupland C.
    BMJ; 2016 Mar 30; 352():i1450. PubMed ID: 27029547
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Metformin hydrochloride in the treatment of type 2 diabetes mellitus: a clinical review with a focus on dual therapy.
    Setter SM, Iltz JL, Thams J, Campbell RK.
    Clin Ther; 2003 Dec 30; 25(12):2991-3026. PubMed ID: 14749143
    [Abstract] [Full Text] [Related]

  • 28. The role of sulphonylureas in the management of type 2 diabetes mellitus.
    Rendell M.
    Drugs; 2004 Dec 30; 64(12):1339-58. PubMed ID: 15200348
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Rosiglitazone.
    Balfour JA, Plosker GL.
    Drugs; 1999 Jun 30; 57(6):921-30; discussion 931-2. PubMed ID: 10400405
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.
    Strowig SM, Raskin P.
    Diabetes Obes Metab; 2005 Nov 30; 7(6):633-41. PubMed ID: 16219007
    [Abstract] [Full Text] [Related]

  • 33. Rosiglitazone: a review of its use in the management of type 2 diabetes mellitus.
    Wagstaff AJ, Goa KL.
    Drugs; 2002 Nov 30; 62(12):1805-37. PubMed ID: 12149047
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.
    Williams D, Feely J.
    Clin Pharmacokinet; 2002 Nov 30; 41(5):343-70. PubMed ID: 12036392
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Comparative tolerability profiles of oral antidiabetic agents.
    Krentz AJ, Ferner RE, Bailey CJ.
    Drug Saf; 1994 Oct 30; 11(4):223-41. PubMed ID: 7848543
    [Abstract] [Full Text] [Related]

  • 40. New approaches to treating type 2 diabetes mellitus in the elderly: role of incretin therapies.
    Abbatecola AM, Maggi S, Paolisso G.
    Drugs Aging; 2008 Oct 30; 25(11):913-25. PubMed ID: 18947259
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.